Member Login

    
              Click here if you forgot your password.

Current Events

Live Online – Qualified Person Education Course

30 June - 1 July 2021


EQPA Members Area

IMP Working Group Members Area


Document and track your personal development - with the Continuous Professional Development (CPD) Documentation Template

To access the template for documenting and tracking your past and ongoing activities, please go here.

After filling out the form, you will be able to create and print out a PDF file.

Authority News

<< Back to overview

 

23 November 2005

EMEA:
Questions and Answers on PAT (update concerning process validation)

A number of answers to frequently asked questions on PAT been added to the website.

  • When PAT is implemented will the manufacturer be allowed to make changes to the process without need for regulatory "approval"?

  • Is it possible for a product to have two specifications - one for real-time release based on on-line measurements and another for end-of-life testing?

  • Will it be possible to widen the limits for an "approved product and process specification" if, post-approval, such changes are found to have no significant affect on product quality?

  • Would EMEA consider a validation strategy, which eliminated the need for product equivalence validation (e.g. PQ with 3 batches) if the product/ process signature were qualified at the development stage

You will find the answers to these questions at the European Medicines Agency website

<< Back to overview